企業プロフィール
Revelation Biosciences 株価・ニュース・カタリスト
- ティッカー:
- REVB
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
1.15 USD (+9.63%)
終値
最終更新: 2026年8月17日
4.14M USD
時価総額
株価変動の要因
As of Aug 17, 2026, REVB closed up 9.63% at $1.15. No new same-company headline was identified in the current news window.
企業概要
事業概要
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology. Its story centers on using immune modulation to address difficult inflammatory conditions.
所在地とセクター分類
Revelation is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with an immunology focus.
ビジネスモデルの特徴
The company depends on early clinical and preclinical progress, capital efficiency, and the ability to show that its platform can create differentiated value. Investors watch proof-of-concept data and financing runway.
バイオ業界での位置付け
Revelation occupies a speculative immune-modulation niche within biotech. It is a small company where data quality and strategic focus dominate the stock.
今後のカタリスト
- Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically. The company remains highly dependent on data.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。